First-in-man concomitant mitral valve replacement and coronary artery bypass grafting using a single minimally

Jules Miazza1, Luca Koechlin1, Raban V Jeger2

  • 1Department of Cardiac Surgery, University Hospital Basel, Basel, Switzerland.

Insights

This study shows that combining minimally invasive bypass surgery with transapical mitral valve replacement is a feasible hybrid treatment. This approach offers a less invasive option for complex cardiac conditions.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Coronary artery disease (CAD) and severe mitral regurgitation (MR) often coexist, posing complex treatment challenges.
  • Minimally invasive surgical techniques are advancing, aiming to reduce patient morbidity.

Observation:

  • A 78-year-old woman with CAD and severe MR underwent a hybrid procedure combining minimally invasive direct coronary artery bypass grafting (MIDCAB) and transapical mitral valve replacement (MVR).
  • The procedure was performed via a single anterolateral thoracotomy, utilizing a heart-team approach in a hybrid operating theatre.

Findings:

  • The simultaneous hybrid procedure was technically successful and uneventful.
  • Postoperative echocardiography confirmed excellent valve function with no regurgitation or obstruction and a stable ejection fraction of 50%.

Implications:

  • This hybrid approach demonstrates feasibility for complex cardiac cases, advancing minimally invasive treatment options.
  • The heart-team approach can extend beyond decision-making to encompass hybrid procedural execution for improved patient outcomes.